NK cell immunotherapy has great potential as a safe and effective anticancer therapy yet there are significant challenges for immunotherapy in brain tumors. We have developed a 19F probe with enhanced sensitivity for the purposes of 19F labeling of NK cells to monitor NK cell biodistribution and immunotherapy. In this paper, we report on the relaxometric characteristics of the probe, acquisition optimization, and initial ex vivo imaging tests in murine models. The agent displayed improved sensitivity relative to Celsense and was clearly visible in the cerebral cortex in approximately equivalent amounts that will be used for cell tracking experiments.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords